Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies

<b>Background/Objectives</b>: The stress testing of biotherapeutic products is a critical component of drug development, enabling the assessment of stability, biosimilarity, and degradation pathways. Subjecting biosimilar monoclonal antibodies to controlled stress conditions yields essential insight...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Merve Celik Yamaci, Ceren Pamukcu, Yigit Erdemgil, Ahmet Emin Atik, Zeynep Zulfiye Yildirim Keles, Ozge Can
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2025-04-01
Saila:	Pharmaceuticals
Gaiak:	monoclonal antibody biosimilar mAb forced degradation size exclusion chromatography isoelectric focusing capillary electrophoresis
Sarrera elektronikoa:	https://www.mdpi.com/1424-8247/18/4/579
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!